Trials / Completed
CompletedNCT01291836
Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study
Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin (N-GAL) Evaluation of Symptomatic Heart Failure Study (AKINESIS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 930 (actual)
- Sponsor
- Alere San Diego · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
AKINESIS is a clinical study to assess the utility of blood and urine NGAL tests in predicting worsening kidney function in patients who present with acute heart failure (AHF) and who are treated with diuretics. It is believed that rising NGAL levels in the blood and/or urine can predict acute kidney injury. It is also believed that patients who are admitted to the hospital with high NGAL levels in the blood/urine will have poorer outcomes.
Conditions
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2013-10-01
- Completion
- 2015-06-01
- First posted
- 2011-02-09
- Last updated
- 2024-01-03
- Results posted
- 2018-02-19
Locations
13 sites across 7 countries: United States, Greece, Ireland, Italy, Netherlands, Spain, Switzerland
Source: ClinicalTrials.gov record NCT01291836. Inclusion in this directory is not an endorsement.